IMMUNOMODULATORY MEDICATIONS AND OUTCOMES OF PATIENTS WITH PRE-EXISTING RHEUMATOID ARTHRITIS USING IMMUNE CHECKPOINT INHIBITORS TO TREAT CANCER

被引：0
|
作者：
Arabelovic, S. [1 ]
Mccarter, K. [2 ]
Wolfgang, T. [1 ]
Wang, X. [1 ]
Yoshida, K. [1 ]
Banasiak, E. [1 ]
Qian, G. [1 ]
Kowalski, E. [1 ]
Vanni, K. [1 ]
Leboeuf, N. [3 ]
Buchbinder, E. [4 ]
Gedmintas, L. [1 ]
Macfarlane, L. [1 ]
Rao, D. [1 ]
Shadick, N. [1 ]
Gravallese, E. [1 ]
Sparks, J. [1 ]
机构：
[1] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA USA
[3] Brigham & Womens Hosp, Dept Dermatol, Boston, MA USA
[4] Dana Farber Canc Inst, Dept Med, Boston, MA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Malignancy; Rheumatoid arthritis;
D O I：
10.1136/annrheumdis-2023-eular.2072
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0028
引用
收藏
页码：18 / 19
页数：2
相关论文
共 50 条
  • [31] LEARNING NEEDS ASSESSMENT FOR PATIENTS WITH CANCER AND A PRE-EXISTING AUTOIMMUNE DISEASE WHO ARE CANDIDATES TO RECEIVE IMMUNE CHECKPOINT INHIBITORS
    Lopez-Olivo, M. A.
    Ruiz, J. I.
    Duhon, G. F.
    Altan, M.
    Tawbi, H.
    Diab, A.
    Bingham, C.
    Calabrese, C.
    Volk, R.
    Suarez-Almazor, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1826 - 1826
  • [32] Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors
    Sumimoto, Hidetoshi
    Noda, Satoshi
    Koide, Hiroyoshi
    Douke, Yutaro
    Sakai, Kosuke
    Nishikawa, Akihito
    Tomioka, Azumi
    Hori, Maki
    Nakato, Hiromi
    Kimura, Yuri
    Tokuda, Aya
    Takano, Atsushi
    Teramoto, Koji
    Murata, Satoshi
    Daigo, Yataro
    PLOS ONE, 2024, 19 (07):
  • [33] Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study
    McCarter, Kaitlin R.
    Wolfgang, Taylor
    Arabelovic, Senada
    Wang, Xiaosong
    Yoshida, Kazuki
    Banasiak, Emily P.
    Qian, Grace
    Kowalski, Emily N.
    Vanni, Kathleen M. M.
    LeBoeuf, Nicole R.
    Buchbinder, Elizabeth, I
    Gedmintas, Lydia
    MacFarlane, Lindsey A.
    Rao, Deepak A.
    Shadick, Nancy A.
    Gravallese, Ellen M.
    Sparks, Jeffrey A.
    LANCET RHEUMATOLOGY, 2023, 5 (05): : E274 - E283
  • [34] Understanding how immune checkpoint modulators alter pre-existing rheumatologic disorders in cancer patients
    Nelson, Michelle
    Shirai, Keisuke
    Gupta, Ridhi
    Gilkeson, Gary
    Paulos, Chrystal M.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [35] Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer
    Kehl, Kenneth L.
    Yang, Shihao
    Awad, Mark M.
    Palmer, Nathan
    Kohane, Isaac S.
    Schrag, Deborah
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (06) : 917 - 926
  • [36] Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer
    Kenneth L. Kehl
    Shihao Yang
    Mark M. Awad
    Nathan Palmer
    Isaac S. Kohane
    Deborah Schrag
    Cancer Immunology, Immunotherapy, 2019, 68 : 917 - 926
  • [37] Combining immune-checkpoint inhibitors with tocilizumab to treat a lung adenocarcinoma patient with pre-existing polymyalgia rheumatica: A case report
    Du, Yang
    Liu, Xiao-Yan
    Zhang, Li
    THORACIC CANCER, 2024, 15 (02) : 198 - 200
  • [38] Immune checkpoint inhibition in patients with inactive pre-existing neuromuscular autoimmune diseases
    Snavely, Andrew
    Perez-Torres, Eduardo J.
    Weber, Jeffrey S.
    Sandigursky, Sabina
    Thawani, Sujata P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 438
  • [39] Safety and Effectiveness of Immune Checkpoint Inhibitors Combination versus Single Agent Therapy in Patients with Pre-existing Autoimmune Diseases
    Reid, Pankti
    Sandigursky, Sabina
    Lopez-Olivo, Maria A.
    Song, Juhee
    Safa, Houssein
    Cytryn, Samuel
    Buni, Maryam
    Pavlick, Anna
    Phd, Michelle Krogsgaard
    Abu-Shawer, Osama
    Altan, Mehmet
    Weber, Jeffrey
    Suarez-Almazor, Maria
    Diab, Adi
    Abdel-Wahab, Noha
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1505 - 1507
  • [40] Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
    Mitchell S. von Itzstein
    Amrit S. Gonugunta
    Yiqing Wang
    Thomas Sheffield
    Rong Lu
    Sadia Ali
    Farjana J. Fattah
    Donglu Xie
    Jennifer Cai
    Yang Xie
    David E. Gerber
    Cancer Immunology, Immunotherapy, 2022, 71 : 2169 - 2181
12345